Related Topics

What to Watch Next

Tom-Frieda

Recent Question:

How does intercourse feel with an implant?

Answer-Button
Home » Permanent Solution » AMS 700
AMS 700® Penile Prosthesis
  • Pair of cylinders implanted in the penis
  • Small pump implanted in the scrotum
  • Reservoir implanted in the lower abdomen
  • Fluid is pumped from reservoir to penis, creating erection

Click here for Risk information.

AMS 700® Momentary Squeeze (MS) Penile Prosthesis

The gold standard in function, performance, and satisfaction.

The AMS 700® MSTM Inflatable Penile Prosthesis offers men natural-looking, satisfying erections and a comfortable flaccid state. With a 92% patient satisfaction rate1 and a 96% partner satisfaction rate,1 it is a highly satisfying and innovative way to restore your sexual function.

This penile prosthesis:

  • Is completely concealed within the body
  • Functions like a natural erection, causing the penis to expand in length (AMS 700 LGX only) and girth
  • Inflates to provide rigidity; deflates for concealment
  • Provides a soft, flaccid penile state when deflated

The AMS 700® MSTM Inflatable Penile Prosthesis Series offers a variety of sizes for a custom fit.

The penile prosthesis consists of a reservoir implanted in the abdomen, a pump placed in the scrotum, and a pair of cylinders implanted in the penis. Fluid is pumped from the reservoir to the penis, creating an erection that provides rigidity and girth expansion.

The AMS 700® MSTM is ideal for a man who wants both a natural-looking, rigid erection and a flaccid penis. The best way to determine if the AMS 700® MSTM inflatable penile prosthesis is right for you is to talk to your doctor.

AMS 700® MSTM Inflatable Penile Prosthesis Series:

  • AMS 700 CX - controlled girth expansion
  • AMS 700 LGX - controlled length and girth expansion
  • AMS 700 CXR - controlled girth expansion for narrow or scarred corporal bodies
  1. Montorsi F, Rigatti P, Carmignani G, et al. AMS three-piece inflatable implants for erectile dysfunction: a long-term multi-institutional study in 200 consecutive patients. Eur Urol. 2000;(1):50-55.